LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Profit Margin

The latest profit margin for LFMDP is -0.9% as of June 2026. That compares with -2.88% in the prior-year period — up 68.9% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's historical trend and sector peers before judging valuation or financial health.

Over the past year, LFMDP's profit margin moved from -2.88% to -0.9% — a 68.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's valuation or profitability profile.

Against Healthcare companies, LFMDP currently prints -0.9% for profit margin, while the sector average sits near 9.48%. That is roughly 109.5% below the sector mean. Large gaps often invite a closer look at LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's growth, margins, and balance sheet.

Profit Margin shows how effectively LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A converts resources into returns. At -0.9%, LFMDP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2.88% in the prior-year period — up 68.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LFMDP's profit margin (-0.9%), review year-over-year change from -2.88%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.